Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Loss of Medicare coverage sends Pacific Edge's share prices plummeting over 60%.

flag Pacific Edge, a New Zealand cancer diagnostics company, saw its share prices drop over 60% after the US Medicare provider, Novitas, decided to stop covering the company's Cxbladder tests starting February 23. flag The loss of Medicare coverage, which contributed over half of the company’s revenue, will significantly impact Pacific Edge financially. flag The company is considering legal action and other strategies to regain coverage.

5 Articles